Literature DB >> 18057520

Etiology and pathogenesis of epithelial ovarian cancer.

Samuel C Mok1, Joseph Kwong, William R Welch, Goli Samimi, Laurent Ozbun, Tomas Bonome, Michael J Birrer, Ross S Berkowitz, Kwong-Kwok Wong.   

Abstract

Ovarian cancer is complex disease composed of different histological grades and types. However, the underlying molecular mechanisms involved in the development of different phenotypes remain largely unknown. Epidemiological studies identified multiple exogenous and endogenous risk factors for ovarian cancer development. Among them, an inflammatory stromal microenvironment seems to play a critical role in the initiation of the disease. The interaction between such a microenvironment, genetic polymorphisms, and different epithelial components such as endosalpingiosis, endometriosis, and ovarian inclusion cyst in the ovarian cortex may induce different genetic changes identified in the epithelial component of different histological types of ovarian tumors. Genetic studies on different histological grades and types provide insight into the pathogenetic pathways for the development of different disease phenotypes. However, the link between all these genetic changes and the etiological factors remains to be established.

Entities:  

Mesh:

Year:  2007        PMID: 18057520      PMCID: PMC3851194          DOI: 10.1155/2007/474320

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  18 in total

1.  Meta-analysis shows significant association of the TP53 Arg72Pro with ovarian cancer risk.

Authors:  Su-Qin Shen; De-Ke Jiang; Guo-Yuan Liu; Fang Chen; Long Yu
Journal:  Mol Biol Rep       Date:  2011-09-28       Impact factor: 2.316

2.  The loss of Hoxa5 function causes estrous acyclicity and ovarian epithelial inclusion cysts.

Authors:  Gaëlle Gendronneau; Olivier Boucherat; Josée Aubin; Margot Lemieux; Lucie Jeannotte
Journal:  Endocrinology       Date:  2012-02-07       Impact factor: 4.736

3.  Impact of post-operative hormone replacement therapy on life quality and prognosis in patients with ovarian malignancy.

Authors:  Li Li; Zhongmian Pan; Kun Gao; Wei Zhang; Yuan Luo; Zhongqiang Yao; Xinqiang Liang; Bujian Tang; Qingdi Quentin Li
Journal:  Oncol Lett       Date:  2011-10-25       Impact factor: 2.967

4.  Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer.

Authors:  Pierre-Luc Mercier; Magdalena Bachvarova; Marie Plante; Jean Gregoire; Marie-Claude Renaud; Karim Ghani; Bernard Têtu; Isabelle Bairati; Dimcho Bachvarov
Journal:  Mol Oncol       Date:  2011-07-26       Impact factor: 6.603

5.  CDKN3 knockdown reduces cell proliferation, invasion and promotes apoptosis in human ovarian cancer.

Authors:  Li-Ping Zhang; Wen-Juan Li; Yuan-Fang Zhu; Shu-Ying Huang; Shan-Yu Fang; Li Shen; Yan-Ling Gao
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 6.  Current understanding of risk factors for ovarian cancer.

Authors:  Thanasak Sueblinvong; Michael E Carney
Journal:  Curr Treat Options Oncol       Date:  2009-07-15

7.  Pelvic endometriosis is rarely associated with ovarian borderline tumours, cytologic and architectural atypia: a clinicopathologic study.

Authors:  Mohamed Ali Bedaiwy; Mahmoud Rezk Abd-Elwahed Hussein; Charles Biscotti; Tommaso Falcone
Journal:  Pathol Oncol Res       Date:  2008-06-25       Impact factor: 3.201

Review 8.  Genomic analysis of epithelial ovarian cancer.

Authors:  John Farley; Laurent L Ozbun; Michael J Birrer
Journal:  Cell Res       Date:  2008-05       Impact factor: 25.617

9.  Ovarian epithelial-stromal interactions: role of interleukins 1 and 6.

Authors:  Kamisha T Woolery; Patricia A Kruk
Journal:  Obstet Gynecol Int       Date:  2011-06-26

10.  Epithelial ovarian carcinoma types and the coexistence of ovarian tumor conditions.

Authors:  Catharina C van Niekerk; Johan Bulten; José A A M van Dijck; André L M Verbeek
Journal:  ISRN Obstet Gynecol       Date:  2011-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.